The rules of immunity: What decides T cell fate?
Silencing KLF2 drove the CD8 T cells along a different path, directing them away from becoming killer cells and toward a ...
Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma
Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...
Pharm Exec26d
FDA Approves Investigational New Drug Application for Fapon Biopharma’s Novel Immunotherapy for Solid Tumors
In mouse studies, it enhanced tumor infiltration, prevented CD8(+) T-cell exhaustion, and increased the production of key immune-activating proteins, including interferon-gamma and granzyme B. In ...
Xenetic presents preclinical data on DNase I with CAR T cells in murine model
Biosciences announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease ...